ArticleMolecules (Basel, Switzerland)2025
Data-Driven Classification of Solubility Space in Deep Eutectic Solvents: Deciphering Driving Forces Using PCA and K-Means Clustering.
Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Navigating the Solubility Landscape of APIs in Deep Eutectic Solvents: A Data-Driven Thermodynamic Taxonomy of Solvation Regimes and Mechanisms.Molecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents a robust, data-driven framework for classifying and predicting drug solubility in deep eutectic solvents (DESs), moving beyond empirical approaches to enable rational formulation design. By analyzing 2010 solubility measurements of 21 diverse pharmaceutical compounds across numerous choline chloride, betaine, and menthol-based DESs, we employed Principal Component Analysis to reduce 16 COSMO-RS-derived descriptors into four chemically interpretable dimensions explaining 86.7% of the total variance. Persistence analysis confirmed component stability, revealing two key factors: PC1 (global solvation propensity, i.e., the overall capacity of the solvent to stabilize solutes through all interaction types) and PC2 (specific interaction complementarity, i.e., the degree of matching between solute and solvent hydrogen-bonding/polarity features). K-means clustering identified four distinct solubility regimes: high-solubility DES-optimized systems (Cluster 1), reliable moderate performers (Cluster 0), intermediate candidates for optimization (Cluster 3), and fundamentally challenging combinations (Cluster 2). Comparative analysis demonstrated choline chloride's broad utility while revealing specialized roles for menthol and betaine in specific chemical spaces. Case studies of Sulfasalazine and Caffeine illustrated how multi-cluster distributions guide formulation strategies, distinguishing precision-requiring from forgiving compounds. This taxonomy provides formulation scientists with a rational framework for DES selection, emphasizing aqueous modification, HBD and HBA diversity, and balanced solvation-interaction optimization. The integrated PCA-clustering approach transforms DES development from trial-and-error screening to targeted design, offering fundamental insights into solubility mechanisms while accelerating sustainable pharmaceutical formulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.